Cargando…
The effect of robenacoxib on the concentration of C-reactive protein in synovial fluid from dogs with osteoarthritis
BACKGROUND: Robenacoxib is a novel and highly selective inhibitor of COX-2 in dogs and cats and because of its acidic nature is regarded as being tissue-selective. Thirty four dogs with stifle osteoarthritis secondary to failure of the cranial cruciate ligament were recruited into this study. Lamene...
Autores principales: | Bennett, David, Eckersall, Peter David, Waterston, Mary, Marchetti, Veronica, Rota, Alessandra, McCulloch, Eilidh, Sbrana, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610148/ https://www.ncbi.nlm.nih.gov/pubmed/23452411 http://dx.doi.org/10.1186/1746-6148-9-42 |
Ejemplares similares
-
Influence of sevoflurane anesthesia with mechanical ventilation and fluid-therapy on distribution of subcutaneously administered robenacoxib in dogs
por: OYAMA, Norihiko, et al.
Publicado: (2018) -
Sparing Effect of Robenacoxib on the Minimum Alveolar Concentration for
Blunting Adrenergic Response (MAC-BAR) of Sevoflurane in Dogs
por: TAMURA, Jun, et al.
Publicado: (2013) -
Robenacoxib in the treatment of pain in cats and dogs: safety, efficacy, and place in therapy
por: Kongara, Kavitha, et al.
Publicado: (2018) -
Evaluation of the Effects of Undenatured Type II Collagen (UC-II) as Compared to Robenacoxib on the Mobility Impairment Induced by Osteoarthritis in Dogs
por: Stabile, Marzia, et al.
Publicado: (2019) -
Safety evaluation of the interchangeable use of robenacoxib (Onsior™) tablets and solution for injection in dogs
por: Toutain, Céline E., et al.
Publicado: (2017)